맥스사이트 (MXCT) 주가

맥스사이트(MXCT)는 NASDAQ에 상장된 Healthcare · Medical Devices 기업입니다. 현재가 $1.39 (+9.45%), 시가총액 $0.09B, 52주 범위 $0.68 ~ $2.92.

MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's products consists of ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. It also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electropo

핵심 지표

• 현재가: $1.39 (+9.45%)
• 시가총액: $0.09B
• 52주 최저~최고: $0.68 ~ $2.92
• 섹터: Healthcare
• 산업: Medical Devices
• 거래소: NASDAQ

맥스사이트의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackQuant에서 실시간으로 확인할 수 있습니다.

맥스사이트 재무 요약

애널리스트 전망

• 투자의견 컨센서스: 5

핵심 재무비율 · 수익성 · 성장성

• PBR (주가순자산비율): 0.53
• 순이익률: -1.35%
• 영업이익률: -0.95%

자주 묻는 질문